Уважаемые посетители НМИЦ онкологии им. Н.Н. Петрова! Обратите внимание, что в пос. Песочный на Ленинградской улице располагаются три разных онкоцентра. При планировании визита запомните наш адрес: СПб, пос. Песочный, ул. Ленинградская, 68.
Размер:
AAA
Цвет: CCC
Изображения вкл.выкл.
Обычная версия сайта

Основные публикации коллектива лаборатории:

  1. Imyanitov E.N., Demidova I.A., Gordiev M.G., Filipenko M.L., Kekeyeva T.V., Moliaka Y.K., Gervas P.A., Kozhemyako V.B., Vodolazhskiy D.I., Sergeyeva L.A., Fattakhova D.U., Iyevleva A.G., Mitiushkina N.V., Kuligina E.S., Barinov A.A., Mommaeva M.S., Aleksakhina S.N., Tsimafeyeu I.V., Tjulandin S.A. Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer // Mol Diagn Ther, 2016 (1-6).
  2. Moiseyenko F.V., Moiseyenko V.M., Aleksakhina S.N., Chubenko V.A., Volkov N.M., Kozyreva K.S., Kramchaninov M.M., Zhuravlev A.S., Shelekhova K.V., Ivantsov A.O., Venina A.R., Preobrazhenskaya E.V., Mitiushkina N.V., Iyevleva A.G., Imyanitov E.N. Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression // Oncology Research and Treatment, 2016, Vol.39(10), P. 605-614.
  3. Frank G.A., Aleksakhina S.N., Zavalishina L.E., Kekeyeva T.V., Venina A.R., Ivantsov A.O., Mitiushkina N.V., Moiseyenko A.V., Pfeifer W., Strelkova T.N., Imyanitov E.N. BRAF and NRAS mutations in Russian melanoma patients: results of a nationwide study // Melanoma Res, 2016, Vol. 26, P. 442–447.
  4. Sokolenko AP, Volkov NM, Preobrazhenskaya EV, Suspitsin EN, Garifullina AR,Ivantsov AV, Togo AV, Imyanitov EN. Evidence for a pathogenic role of BRCA1 L1705P and W1837X germ-line mutations. Mol Biol Rep. 2016 May;43(5):335-8.
  5. Iyevleva AG, Raskin GA, Tiurin VI, Sokolenko AP, Mitiushkina NV, Aleksakhina SN, Garifullina AR, Strelkova TN, Merkulov VO, Ivantsov AO, Kuligina ESh,Pozharisski KM, Togo AV, Imyanitov EN. Novel ALK fusion partners in lung cancer. Cancer Lett. 2015 Jun 28;362(1):116-21. doi: 10.1016/j.canlet.2015.03.028.
  6. Sokolenko AP, Suspitsin EN, Kuligina ESh, Bizin IV, Frishman D, Imyanitov EN. Identification of novel hereditary cancer genes by whole exome sequencing. Cancer Lett. 2015 Dec 28;369(2):274-88.
  7. Tjulandin S, Imyanitov E, Moiseyenko V, Ponomarenko D, Gurina L, Koroleva I, Karaseva V. Prospective cohort study of clinical characteristics and management patterns for patients with non-small-cell lung cancer in the Russian Federation: EPICLIN-Lung. Curr Med Res Opin. 2015 Jun;31(6):1117-27. doi:10.1185/03007995.2015.1036015.
  8. Iyevleva AG, Mitiushkina NV, Karaseva NA, Orlov SV, Volodina LN, Kulikova YE, Lozhkina AM, Ivantsov AO, Tiurin VI, Togo AV, Imyanitov EN. Lung carcinomas with EGFR exon 19 insertions are sensitive to gefitinib treatment. J Thorac Oncol. 2014 Apr;9(4):e31-3. doi: 10.1097/JTO.0000000000000106.
  9. Sokolenko AP, Bogdanova N, Kluzniak W, Preobrazhenskaya EV, Kuligina ES, Iyevleva AG, Aleksakhina SN, Mitiushkina NV, Gorodnova TV, Bessonov AA, Togo AV, Lubinski J, Cybulski C, Jakubowska A, Dork T, Imyanitov EN. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations. Breast Cancer Res Treat. 2014 Jun;145(2):553-62.
  10. Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, Matsko DE, Semiglazov VF, Fichtner I, Larionov AA, Kuznetsov SG, Antoniou AC, Imyanitov EN. High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia. Int J Cancer. 2012 Jun 15;130(12):2867-73.
  11. Kuligina E, Reiner A, Imyanitov EN, Begg CB. Evaluating cancer epidemiologic risk factors using multiple primary malignancies. Epidemiology. 2010 May;21(3):366-72. doi: 10.1097/EDE.0b013e3181cc8871.
  12. Iyevleva AG, Suspitsin EN, Kroeze K, Gorodnova TV, Sokolenko AP, Buslov KG, Voskresenskiy DA, Togo AV, Kovalenko SP, Stoep N, Devilee P, Imyanitov EN. Non-founder BRCA1 mutations in Russian breast cancer patients. Cancer Lett. 2010 Dec 8;298(2):258-63.
  13. Sokolenko AP, Iyevleva AG, Mitiushkina NV, Suspitsin EN, Preobrazhenskaya EV, Kuligina ESh, Voskresenskiy DA, Lobeiko OS, Krylova NY, Gorodnova TV, Buslov KG, Bit-Sava EM, Dolmatov GD, Porhanova NV, Polyakov IS, Abysheva SN, Katanugina AS, Baholdin DV, Yanus GA, Togo AV, Moiseyenko VM, Maximov SY, Semiglazov VF, Imyanitov EN. Hereditary breast-ovarian cancer syndrome in Russia. Acta Naturae. 2010 Oct;2(4):31-5.
  14. Iyevleva AG, Novik AV, Moiseyenko VM, Imyanitov EN. EGFR mutation in kidney carcinoma confers sensitivity to gefitinib treatment: a case report. Urol Oncol. 2009 Sep-Oct;27(5):548-50. doi: 10.1016/j.urolonc.2008.03.022.
  15. Suspitsin EN, Sokolenko AP, Togo AV, Lazareva YR, Turkevich EA, Matsko DE,Henrich KO, Borresen-Dale AL, Schwab M, Cornelisse CJ, Imyanitov EN. Nonrandom distribution of oncogene amplifications in bilateral breast carcinomas: Possible role of host factors and survival bias. Int J Cancer. 2007 Jan 15;120(2):297-302.
  16. Sokolenko AP, Rozanov ME, Mitiushkina NV, Sherina NY, Iyevleva AG, Chekmariova EV, Buslov KG, Shilov ES, Togo AV, Bit-Sava EM, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. Founder mutations in early-onset, familial and bilateral breast cancer patients from Russia. Fam Cancer. 2007 6(3):281-6.
  17. Chekmariova EV, Sokolenko AP, Buslov KG, Iyevleva AG, Ulibina YM, Rozanov ME, Mitiushkina NV, Togo AV, Matsko DE, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse C, Semiglazov VF, Imyanitov EN. CHEK2 1100delC mutation is frequent among Russian breast cancer patients. Breast Cancer Res Treat. 2006 Nov;100(1):99-102.
  18. Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, Kuligina ESh, Ulibina YM, Rozanov ME, Suspitsin EN, Matsko DE, Chagunava OL, Trofimov DY, Devilee P, Cornelisse C, Togo AV, Semiglazov VF, Imyanitov EN. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer. 2006 Jul;42(10):1380-4.
  19. Buslov KG, Iyevleva AG, Chekmariova EV, Suspitsin EN, Togo AV, Kuligina ESh, Sokolenko AP, Matsko DE, Turkevich EA, Lazareva YR, Chagunava OL, Bit-Sava EM, Semiglazov VF, Devilee P, Cornelisse C, Hanson KP, Imyanitov EN. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia. Int J Cancer. 2005 Apr 20;114(4):585-9.
  20. Imyanitov EN, Suspitsin EN, Grigoriev MY, Togo AV, Kuligina ESh, Belogubova EV, Pozharisski KM, Turkevich EA, Rodriquez C, Cornelisse CJ, Hanson KP, Theillet C. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. Int J Cancer. 2002 Aug 10;100(5):557-64.

Заказать обратный звонок

Оператор call-центра перезвонит Вам в течение суток с 9.00 до 21.00

Записаться на прием

Оператор call-центра свяжется с Вами с 09.00 до 21.00 для подтверждения Вашего визита к врачу

Написать письмо
Кому
ФИО автора
Телефон *

Внимание! Согласно 59-ФЗ «О порядке рассмотрения обращений граждан Российской Федерации»
Вы получите официальный ответ в течение 30 дней

Обращение *
Не более одного файла в формате pdf или jpg, размером до 5 Мб